S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
3 EV Stocks You Need To Have On Your Watchlist
"Unknown laser company making HUGE profit from Russia-Ukraine War" (Ad)
Will NIO Partake In China's Economic Awakening?
BJ's Restaurants' Approaching Buy Point As Earnings Surge 150%
66,000% upside on tiny biotech? (Ad)
Cactus Opens The Cash Flow Wellhead With Flexsteel Acquisition 
Tax Software Specialist Vertex In Buy Zone After Base Breakout
Trade Smarter: Discover Hidden Opportunities w/ A.I. (Ad)
How to Choose a Brokerage Account or Online Broker
Will Plug Power’s Deal With Energy Vault Move The Needle? 
S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
3 EV Stocks You Need To Have On Your Watchlist
"Unknown laser company making HUGE profit from Russia-Ukraine War" (Ad)
Will NIO Partake In China's Economic Awakening?
BJ's Restaurants' Approaching Buy Point As Earnings Surge 150%
66,000% upside on tiny biotech? (Ad)
Cactus Opens The Cash Flow Wellhead With Flexsteel Acquisition 
Tax Software Specialist Vertex In Buy Zone After Base Breakout
Trade Smarter: Discover Hidden Opportunities w/ A.I. (Ad)
How to Choose a Brokerage Account or Online Broker
Will Plug Power’s Deal With Energy Vault Move The Needle? 
S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
3 EV Stocks You Need To Have On Your Watchlist
"Unknown laser company making HUGE profit from Russia-Ukraine War" (Ad)
Will NIO Partake In China's Economic Awakening?
BJ's Restaurants' Approaching Buy Point As Earnings Surge 150%
66,000% upside on tiny biotech? (Ad)
Cactus Opens The Cash Flow Wellhead With Flexsteel Acquisition 
Tax Software Specialist Vertex In Buy Zone After Base Breakout
Trade Smarter: Discover Hidden Opportunities w/ A.I. (Ad)
How to Choose a Brokerage Account or Online Broker
Will Plug Power’s Deal With Energy Vault Move The Needle? 
S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
3 EV Stocks You Need To Have On Your Watchlist
"Unknown laser company making HUGE profit from Russia-Ukraine War" (Ad)
Will NIO Partake In China's Economic Awakening?
BJ's Restaurants' Approaching Buy Point As Earnings Surge 150%
66,000% upside on tiny biotech? (Ad)
Cactus Opens The Cash Flow Wellhead With Flexsteel Acquisition 
Tax Software Specialist Vertex In Buy Zone After Base Breakout
Trade Smarter: Discover Hidden Opportunities w/ A.I. (Ad)
How to Choose a Brokerage Account or Online Broker
Will Plug Power’s Deal With Energy Vault Move The Needle? 
OTCMKTS:IMUC

EOM Pharmaceuticals (IMUC) Stock Forecast, Price & News

$0.35
+0.14 (+67.31%)
(As of 06/9/2023 ET)
Compare
Today's Range
$0.21
▼
$0.35
50-Day Range
$0.20
▼
$0.35
52-Week Range
$0.16
▼
$0.94
Volume
576 shs
Average Volume
576 shs
Market Capitalization
$1.46 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
ProfileChartCompetitorsFinancialsInsider TradesHeadlinesSEC FilingsShort Interest

IMUC stock logo

About EOM Pharmaceuticals (OTCMKTS:IMUC) Stock

EOM Pharmaceuticals Holdings, Inc. is a clinical-stage biotechnology company, which engages in the development of drugs with the potential to transform therapeutic paradigms. Its pipeline includes EOM613 and EOM147. The company was founded on March 20, 1987 and is headquartered in Montvale, NJ.

Receive IMUC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for EOM Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

IMUC Stock News Headlines

May 16, 2023 | msn.com
Trade commission fights Amgen's $28B purchase of Horizon Therapeutics
May 16, 2023 | americanbankingnews.com
EOM Pharmaceuticals (OTCMKTS:IMUC) & OPKO Health (NASDAQ:OPK) Critical Contrast
June 10, 2023 | Legacy Research (Affiliate) (Ad)
Sell Every Stock, Except ONE (Ticker Revealed)
We saw one of the longest bull markets in history, with the S&P surging well over 800% But now the chickens have come home to roost. However, Jeff Clark couldn’t care less because he ignores almost every single stock in the market.
May 10, 2023 | msn.com
Pharma CEOs to testify in U.S. Senate hearing on insulin prices
May 10, 2023 | marketwatch.com
8-K: Acumen Pharmaceuticals, Inc.
May 9, 2023 | msn.com
Olema Pharmaceuticals GAAP EPS of -$0.70 misses by $0.04
May 9, 2023 | investing.com
OliX Pharmaceuticals Inc (226950)
April 2, 2023 | americanbankingnews.com
EOM Pharmaceuticals Holdings, Inc. (OTCMKTS:IMUC) Short Interest Up 20.0% in March
June 10, 2023 | Legacy Research (Affiliate) (Ad)
Sell Every Stock, Except ONE (Ticker Revealed)
We saw one of the longest bull markets in history, with the S&P surging well over 800% But now the chickens have come home to roost. However, Jeff Clark couldn’t care less because he ignores almost every single stock in the market.
March 30, 2023 | msn.com
USFDA gives final nod to Alembic Pharmaceuticals’ Glaucoma drug
March 27, 2023 | reuters.com
U.S. Supreme Court mulls Amgen bid to revive cholesterol drug patents
March 13, 2023 | marketwatch.com
Regeneron Pharmaceuticals Inc. stock underperforms Monday when compared to competitors despite daily gains
March 11, 2023 | finance.yahoo.com
EOM Pharmaceuticals Holdings, Inc. (IMUC)
February 24, 2023 | seekingalpha.com
Ionis Pharmaceuticals, Inc. (IONS) Q4 2022 Earnings Call Transcript
December 8, 2022 | technews.tmcnet.com
AltruBio Hosting Research & Development Update on Immune Checkpoint Enhancer Platform for T Cell Mediated Immunological Diseases
November 29, 2022 | marketwatch.com
Alaunos Therapeutics Shares Drop 24% After Public Offering Prices
October 6, 2022 | marketwatch.com
InVivo Therapeutics Adds to Surge After Hours, Recently at $10.85
October 3, 2022 | benzinga.com
Imunon Appoints James E. Dentzer to its Board of Directors
September 21, 2022 | morningstar.com
Seres Therapeutics Inc MCRB Stock Quote
September 14, 2022 | benzinga.com
ImmunoGen Announces Webcast of Presentation and Q&A at Upcoming Guggenheim Nantucket Therapeutics Conference
September 11, 2022 | reuters.com
ImmunoCellular Therapeutics Ltd
June 28, 2022 | seekingalpha.com
EOM Pharmaceutical Files For $25 Million IPO Uplisting To Nasdaq
June 24, 2022 | seekingalpha.com
EOM Pharmaceuticals files to uplist to Nasdaq
December 2, 2021 | finance.yahoo.com
EOM Pharmaceuticals, Inc. And Immunocellular Therapeutics, Ltd. Announce Entry Into And Close Of Definitive Merger Agreement
July 17, 2021 | nasdaq.com
Immunocellular Therapeutics Ltd (IMUC)
June 28, 2021 | finance.yahoo.com
ImmunoCellular Therapeutics Announces Application for Continued Public Quoting on the Over-the-Counter (OTC) Market
September 10, 2020 | marketwatch.com
Dendritic Cell Therapy Market Insights By Size, Share, Future Growth And Forecast From 2020-2028
See More Headlines

IMUC Price History

IMUC Company Calendar

Last Earnings
8/13/2018
Today
6/10/2023
Fiscal Year End
12/31/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:IMUC
CUSIP
N/A
CIK
822411
Web
www.imuc.com
Phone
(201) 351-0605
Fax
818-224-5287
Employees
4
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
4,200,000
Free Float
4,057,000
Market Cap
$1.46 million
Optionable
Not Optionable
Beta
1.00

Key Executives

  • Eli Goldberger
    Chairman & Chief Operating Officer
  • Irach B. Taraporewala
    President, Chief Executive Officer & Director
  • Wayne I. Danson
    Chief Financial Officer & Treasurer
  • Shalom Z. Hirschman
    Chief Scientific Officer & Medical Director

Key Competitors

View All Competitors













IMUC Stock - Frequently Asked Questions

How have IMUC shares performed in 2023?

EOM Pharmaceuticals' stock was trading at $0.8197 at the start of the year. Since then, IMUC shares have decreased by 57.5% and is now trading at $0.3480.
View the best growth stocks for 2023 here.

How were EOM Pharmaceuticals' earnings last quarter?

EOM Pharmaceuticals Holdings, Inc. (OTCMKTS:IMUC) posted its earnings results on Monday, August, 13th. The company reported ($0.01) EPS for the quarter.

What is EOM Pharmaceuticals' stock symbol?

EOM Pharmaceuticals trades on the OTCMKTS under the ticker symbol "IMUC."

How do I buy shares of EOM Pharmaceuticals?

Shares of IMUC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is EOM Pharmaceuticals' stock price today?

One share of IMUC stock can currently be purchased for approximately $0.35.

How much money does EOM Pharmaceuticals make?

EOM Pharmaceuticals (OTCMKTS:IMUC) has a market capitalization of $1.46 million.

How can I contact EOM Pharmaceuticals?

EOM Pharmaceuticals' mailing address is 23622 CALABASAS ROAD SUITE 300, CALABASAS CA, 91302. The official website for the company is www.imuc.com. The company can be reached via phone at (201) 351-0605, via email at ir-pr@imuc.com, or via fax at 818-224-5287.

This page (OTCMKTS:IMUC) was last updated on 6/10/2023 by MarketBeat.com Staff

My Account -